XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Equity Attributable to Breckenridge Prior to Acquisition
Common Stock
Additional Paid-in Capital
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Total
Balance at beginning of period at Dec. 31, 2021   $ 237 $ 155,268 $ (92,018) $ (1,010) $ 62,477
Balance at beginning of period (in shares) at Dec. 31, 2021   23,692,379        
Increase (Decrease) in Stockholders' Equity            
Net income (loss) $ 1,006     (2,391)   (1,385)
Unrealized income (loss) on foreign exchange rate translation         (233) (233)
Issuance of common stock under stock compensation plans   $ 1 (1)      
Issuance of common stock under stock compensation plans (in shares)   155,000        
Stock-based compensation expense     279     279
Shares exchanged for taxes on stock-based compensation     (79)     (79)
Shares exchanged for taxes on stock-based compensation (in shares)   (35,050)        
Treasury stock sale     113     113
Deemed contribution of Breckenridge net assets 6,472         6,472
Breckenridge cash contributions prior to acquisition 1,950         1,950
Balance at end of period at Mar. 31, 2022 9,428 $ 238 155,580 (94,409) (1,243) 69,594
Balance at end of period (in shares) at Mar. 31, 2022   23,812,329        
Balance at beginning of period at Dec. 31, 2021   $ 237 155,268 (92,018) (1,010) 62,477
Balance at beginning of period (in shares) at Dec. 31, 2021   23,692,379        
Increase (Decrease) in Stockholders' Equity            
Net income (loss)           (15,876)
Deemed distributions of Breckenridge net assets not acquired           0
Deemed contribution of Breckenridge net assets           6,472
Balance at end of period at Sep. 30, 2022 7,340 $ 238 155,413 (109,690) (2,248) 51,053
Balance at end of period (in shares) at Sep. 30, 2022   23,812,329        
Balance at beginning of period at Mar. 31, 2022 9,428 $ 238 155,580 (94,409) (1,243) 69,594
Balance at beginning of period (in shares) at Mar. 31, 2022   23,812,329        
Increase (Decrease) in Stockholders' Equity            
Net income (loss) 99     (7,678)   (7,579)
Unrealized income (loss) on foreign exchange rate translation         (439) (439)
Stock-based compensation expense     89     89
Breckenridge cash contributions prior to acquisition 1,921         1,921
Balance at end of period at Jun. 30, 2022 11,448 $ 238 155,669 (102,087) (1,682) 63,586
Balance at end of period (in shares) at Jun. 30, 2022   23,812,329        
Increase (Decrease) in Stockholders' Equity            
Cash distributions (4,799)         (4,799)
Net income (loss) 691     (7,603)   (6,912)
Cash settlement of RSUs     (301)     (301)
Unrealized income (loss) on foreign exchange rate translation         (566) (566)
Stock-based compensation expense     45     45
Balance at end of period at Sep. 30, 2022 7,340 $ 238 155,413 (109,690) (2,248) 51,053
Balance at end of period (in shares) at Sep. 30, 2022   23,812,329        
Balance at beginning of period at Dec. 31, 2022 7,695 $ 238 155,413 (112,469) (2,073) $ 48,804
Balance at beginning of period (in shares) at Dec. 31, 2022   23,812,329       23,812,329
Increase (Decrease) in Stockholders' Equity            
Net income (loss) (976)     563   $ (413)
Unrealized income (loss) on foreign exchange rate translation         (6) (6)
Issuance of stock for Breckenridge acquisition (1,335) $ 12 2,008     685
Issuance of stock for Breckenridge acquisition (in shares)   1,188,235        
Excess of purchase price over net assets acquired     (10,565)     (10,565)
Breckenridge cash distributions prior to acquisition (3,055)         (3,055)
Deemed distributions of Breckenridge net assets not acquired (2,329)         (2,329)
Balance at end of period at Mar. 31, 2023   $ 250 146,856 (111,906) (2,079) 33,121
Balance at end of period (in shares) at Mar. 31, 2023   25,000,564        
Balance at beginning of period at Dec. 31, 2022 $ 7,695 $ 238 155,413 (112,469) (2,073) $ 48,804
Balance at beginning of period (in shares) at Dec. 31, 2022   23,812,329       23,812,329
Increase (Decrease) in Stockholders' Equity            
Net income (loss)           $ (10,041)
Deemed distributions of Breckenridge net assets not acquired           (2,329)
Balance at end of period at Sep. 30, 2023   $ 308 156,678 (121,534) (2,048) $ 33,404
Balance at end of period (in shares) at Sep. 30, 2023   30,812,329       30,812,329
Balance at beginning of period at Mar. 31, 2023   $ 250 146,856 (111,906) (2,079) $ 33,121
Balance at beginning of period (in shares) at Mar. 31, 2023   25,000,564        
Increase (Decrease) in Stockholders' Equity            
Net income (loss)       (4,430)   (4,430)
Unrealized income (loss) on foreign exchange rate translation         249 249
Balance at end of period at Jun. 30, 2023   $ 250 146,856 (116,336) (1,830) 28,940
Balance at end of period (in shares) at Jun. 30, 2023   25,000,564        
Increase (Decrease) in Stockholders' Equity            
Net income (loss)       (5,198)   (5,198)
Unrealized income (loss) on foreign exchange rate translation         (218) (218)
Issuance of stock for convertible note   $ 58 9,822     9,880
Issuance of stock for convertible note (in shares)   5,811,765        
Balance at end of period at Sep. 30, 2023   $ 308 $ 156,678 $ (121,534) $ (2,048) $ 33,404
Balance at end of period (in shares) at Sep. 30, 2023   30,812,329       30,812,329